Recent Patents, Formulation Techniques, Classification and Characterization of Liposomes

被引:41
作者
Sheoran, Reena [1 ]
Khokra, Sukhbir Lal [1 ]
Chawla, Viney [2 ]
Dureja, Harish [3 ]
机构
[1] Kurukshetra Univ, Inst Pharmaceut Sci, Kurukshetra 136119, Haryana, India
[2] Baba Farid Univ Hlth Sci, Univ Inst Pharmaceut Sci & Res, Dept Pharmaceut, Faridkot 151203, India
[3] Maharshi Dayanand Univ, Dept Pharmaceut Sci, Rohtak 124001, Haryana, India
关键词
Liposomes; phospholipids; formulation; characterization; encapsulation; biocompatible; DRUG-DELIVERY SYSTEMS; RETICULOENDOTHELIAL SYSTEM; CIRCULATION TIME; PHOSPHATIDYLCHOLINE; CHOLESTEROL; SERUM; PHARMACOKINETICS; NANOPARTICLES; VINCRISTINE; CLEARANCE;
D O I
10.2174/1872210513666181127110413
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Background: During past decades, liposomes have emerged as efficient carriers for drugs, diagnostics, vaccines, nutrients and other bioactive agents. Liposomes, the spherical vesicles consisting of phospholipids bilayer have the ability to encapsulate both lipophilic and hydrophilic drugs. Extensive studies have been done in the past for investigating a number of drugs and genes for controlled release with liposomal formulation. Liposomes have also been investigated for their use in cancer treatment. Liposomes offer various advantages because of their biocompatible, biodegradable, nontoxic and non-immunogenic nature. Methods: Liposomes have cell-specific targeting with important applications in the fields of nanotechnology like cancer therapy, diagnosis, gene delivery, cosmetics, agriculture and in food technology. They are prepared by various methods like sonication method, ethanol injection method, lipid film hydration method, micro-emulsion method. Conclusion: This review will provide an overview of classification, the various formulation methods, characterization, patented formulations and applications of liposomes with future prospects.
引用
收藏
页码:17 / 27
页数:11
相关论文
共 95 条
  • [21] Cagdas M., 2014, Application of nanotechnology in drug delivery, V1, P1, DOI [10.5772/58459, DOI 10.5772/58459]
  • [22] Fighting Cancer: From the Bench to Bedside Using Second Generation Cationic Liposomal Therapeutics
    Campbell, Robert B.
    Ying, Bo
    Kuesters, Geoffrey M.
    Hemphill, Ryan
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (02) : 411 - 429
  • [23] Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy
    Chang, Hsin-I
    Yeh, Ming-Kung
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 : 49 - 60
  • [24] Cronstein BN, 2018, US Patent, Patent No. 20180036238
  • [25] LATERAL DIFFUSION RATES OF PHOSPHATIDYLCHOLINE IN VESICLE MEMBRANES - EFFECTS OF CHOLESTEROL AND HYDROCARBON PHASE-TRANSITIONS
    CULLIS, PR
    [J]. FEBS LETTERS, 1976, 70 (01) : 223 - 228
  • [26] THE BILAYER STABILIZING ROLE OF SPHINGOMYELIN IN THE PRESENCE OF CHOLESTEROL - A P-31 NMR-STUDY
    CULLIS, PR
    HOPE, MJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 597 (03) : 533 - 542
  • [27] Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine
    Davis, Tyler
    Farag, Sherif S.
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 : 3479 - 3488
  • [28] DEAMER D, 1976, BIOCHIM BIOPHYS ACTA, V443, P629, DOI 10.1016/0005-2787(76)90527-X
  • [29] Deepthi V., 2014, RGUHS J PHARM SCI, V4, P47
  • [30] Dua J.S., 2012, Inemational of Pharamceutical Studies and Reseach, V2, P14, DOI DOI 10.1017/CB09781107415324.004